New pharmacological strategy to treat depression in a faster and more effective way
A study led by researchers at the Biomedical Research Institute of Barcelona CSIC (IIBB-CSIC) and the August Pi i Sunyer Biomedical Research Institu1
A study led by researchers at the Biomedical Research Institute of Barcelona CSIC (IIBB-CSIC) and the August Pi i Sunyer Biomedical Research Institu1
The prestigious journal The Lancet publishes a seminar on community-acquired pneumonia written by IDIBAPS researchers. The article reviews the epidem1
Dr. Marc Claret, head of the IDIBAPS group Neural Control of Metabolism, has received one of 63 BBVA Foundation Grants to Researchers and Culture Cr1
Dr. Eduard Vieta, head of the Psychiatry and Psychology department at Hospital Clínic and head of the IDIBAPS research group Biological bases of psyc1
Doctors and researchers from Hospital Clínic and IDIBAPS were awarded in the second Vall d’Hebron Research Institute (VHIR) Health Innovation Contes1
The Spanish Agency for Medicines and Health Products (AEMPS) has approved a clinical trial in humans with an Antigen-Specific therapy with dendritic1
A study, published today in the journal Nature, marks a milestone in the understanding of chronic lymphocytic leukemia, the most common leukemia in1
A study published in the New England Journal of Medicine (NEJM) shows that abnormal lung development before 40 years of age predisposes to a diagnos1
Researchers from IDIBAPS describe a molecular mechanism linking the development of type 2 diabetes with the malfunction of a cell organelle, the end1
Fingolimod, a drug used to treat multiple sclerosis, restores hippocampal synaptic plasticity and improves memory function. This is the main conclus1